Pharmafile Logo
T40 2022 Cover
Diversity, Equity and Inclusion
Communiqué 53 Cover Image
- PMLiVE

Astellas Innovation Debate

UK flag

UK biopharma says Brexit would be “bad for business”

Over 90 industry leaders sign letter supporting the Remain campaign

AstraZeneca AZ

AstraZeneca sets up genomics consortium for drug discovery

Will launch dedicated research centre to analyse data from clinical trials

- PMLiVE

New biosimilars group will tackle slow uptake in UK

Has pledged to increase access to lower-priced versions of biologic drugs

The doctor will see you now?

Access to healthcare and European variation

- PMLiVE

Med comms has a ‘big role to play’ in market access

HCA meeting hears communications can assist companies with the process

- PMLiVE

Norman Lamb: Health savings ‘unachievable’ under current approach

Former minister says health system's ‘existential challenge’ needs new thinking

- PMLiVE

Britain facing social care ‘time bomb’

Raising awareness of financial realities is key first step, Astellas Debate hears

- PMLiVE

How AbbVie Care is putting patients at the centre

And why this is good news for everyone

Shire Basingstoke

Shire launches long-acting ADHD drug Intuniv in UK

Also plans to launch the once-daily treatment in Japan later this year

ABPI London offices

UK pharma’s contribution to NHS hits £1bn mark

ABPI says local access to new treatments still not universal despite drug rebates

- PMLiVE

The growing necessity for pharma to become a true health delivery partner of the NHS

Focus on solving your customer’s biggest problems to create shared value

- PMLiVE

New UK Cancer Drugs Fund takes shape

NICE to manage access to cancer treatments from 1 July

Subscribe to our email news alerts

Latest jobs from #PharmaRole

Latest content

Latest intelligence

Quick links